UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Looking beyond COVID-19 vaccine phase 3 trials

Nature medicine, 2021-02, Vol.27 (2), p.205-211

2021

Link zum Volltext

Verfügbarkeit prüfen

Vaccine development for emerging infectious diseases

Nature medicine, 2021-04, Vol.27 (4), p.591-600

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccine development, access, and equity

The Journal of experimental medicine, 2020-11, Vol.217 (11)

Kim, Jerome H

2020

Link zum Volltext

Verfügbarkeit prüfen

Supply and delivery of vaccines for global health

Current opinion in immunology, 2021-08, Vol.71, p.13-20

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel prime-boost vaccine strategies against HIV-1

Expert review of vaccines, 2019-08, Vol.18 (8), p.765-779

2019

Link zum Volltext

Verfügbarkeit prüfen

Collaborations between product development partnerships and the World Health Organization

Bulletin of the World Health Organization, 2023-05, Vol.101 (5), p.355-357

2023

Link zum Volltext

Verfügbarkeit prüfen

Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection

Annual review of medicine, 2015-01, Vol.66 (1), p.423-437

2015

Link zum Volltext

Verfügbarkeit prüfen

Current approaches to HIV vaccine development: a narrative review

Journal of the International AIDS Society, 2021-11, Vol.24 (S7), p.e25793-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?

The Lancet infectious diseases, 2020-07, Vol.20 (7), p.760-761

2020

Link zum Volltext

Verfügbarkeit prüfen

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

PLoS pathogens, 2015-08, Vol.11 (8), p.e1005042-e1005042

2015

Link zum Volltext

Verfügbarkeit prüfen

The global burden and epidemiology of invasive non-typhoidal Salmonella infections

Human vaccines & immunotherapeutics, 2019-06, Vol.15 (6), p.1421-1426

2019

Link zum Volltext

Verfügbarkeit prüfen

Parting the Clouds over Typhoid with a New Conjugate Vaccine

The New England journal of medicine, 2019-12, Vol.381 (23), p.2262-2264

2019

Link zum Volltext

Verfügbarkeit prüfen

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

The Lancet (British edition), 2021-02, Vol.397 (10274), p.562-564

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database

Journal of medical virology, 2022-03, Vol.94 (3), p.1085-1095

2022

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Proceedings of the National Academy of Sciences - PNAS, 2013-05, Vol.110 (22), p.9019-9024

2013

Link zum Volltext

Verfügbarkeit prüfen

The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics

Clinical infectious diseases, 2019-08, Vol.69 (5), p.877-883

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

Clinical infectious diseases, 2017-01, Vol.64 (2), p.124-131

2017

Link zum Volltext

Verfügbarkeit prüfen

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

PLoS pathogens, 2016-07, Vol.12 (7), p.e1005742-e1005742

2016

Link zum Volltext

Verfügbarkeit prüfen

Circulating HIV-Specific Interleukin-21+CD4+ T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

Immunity (Cambridge, Mass.), 2016-01, Vol.44 (1), p.167-178

2016

Link zum Volltext

Verfügbarkeit prüfen

Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies

Journal of virology, 2014-11, Vol.88 (21), p.12385-12396

2014

Link zum Volltext

Verfügbarkeit prüfen

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

PloS one, 2017-07, Vol.12 (7), p.e0180720-e0180720

2017

Link zum Volltext

Verfügbarkeit prüfen

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Immunity (Cambridge, Mass.), 2013-01, Vol.38 (1), p.176-186

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.925

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.682)
Mit Volltextzugriff
(1.755)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.274)
Life Sciences & Biomedicine
(958)
Humans
(765)
Female
(362)
Male
(350)
Adult
(263)
Middle Aged
(211)
Immunology
(201)
Physical Sciences
(187)
Animals
(175)
Technology
(163)
Infectious Diseases
(160)
Biological And Medical Sciences
(158)
Aged
(148)
Hiv
(139)
Human Immunodeficiency Virus
(138)
Science & Technology - Other Topics
(131)
Life Sciences
(129)
Medical Sciences
(123)
Vaccines
(122)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(126)
Biology Of Blood And Marrow Transplantation
(51)
Plos One
(50)
Journal Of Virology
(27)
Plos Pathogens
(27)
Clinical Infectious Diseases
(24)
Nature
(23)
The New England Journal Of Medicine
(23)
Blood Advances
(21)
Vaccine
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(29)

Menü

Weitere Dienste

Einstellungen

Looking beyond COVID-19 vaccine phase 3 trials

Vaccine development for emerging infectious diseases

SARS-CoV-2 vaccine development, access, and equity

Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

Supply and delivery of vaccines for global health

Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

Novel prime-boost vaccine strategies against HIV-1

Collaborations between product development partnerships and the World Health Organization

Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection

Current approaches to HIV vaccine development: a narrative review

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

The global burden and epidemiology of invasive non-typhoidal Salmonella infections

Parting the Clouds over Typhoid with a New Conjugate Vaccine

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics

Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization

Circulating HIV-Specific Interleukin-21+CD4+ T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions

Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Suchergebnisse filtern